127 related articles for article (PubMed ID: 15684570)
1. Drug dependence, synaptic plasticity, and tissue plasminogen activator.
Yamada K; Nagai T; Nabeshima T
J Pharmacol Sci; 2005 Feb; 97(2):157-61. PubMed ID: 15684570
[TBL] [Abstract][Full Text] [Related]
2. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
Nagai T; Takuma K; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
[TBL] [Abstract][Full Text] [Related]
3. [Role of tissue plasminogen activator in the rewarding effect of morphine].
Nagai T; Nabeshima T; Takuma K; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846
[TBL] [Abstract][Full Text] [Related]
4. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
5. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
[TBL] [Abstract][Full Text] [Related]
6. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
[TBL] [Abstract][Full Text] [Related]
7. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
Nagai T; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
[TBL] [Abstract][Full Text] [Related]
8. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
9. Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Ito M; Nagai T; Mizoguchi H; Sato K; Hayase M; Otsuka N; Fukakusa A; Kumagai N; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Dec; 103(6):2589-96. PubMed ID: 17944865
[TBL] [Abstract][Full Text] [Related]
10. Involvement of tissue plasminogen activator "tPA" in ethanol-induced locomotor sensitization and conditioned-place preference.
Bahi A; Dreyer JL
Behav Brain Res; 2012 Jan; 226(1):250-8. PubMed ID: 21945298
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization.
Bahi A; Dreyer JL
Genes Brain Behav; 2008 Mar; 7(2):244-56. PubMed ID: 17680802
[TBL] [Abstract][Full Text] [Related]
13. Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1.
Nagai T; Nabeshima T; Yamada K
J Pharmacol Sci; 2008 Dec; 108(4):408-14. PubMed ID: 19098386
[TBL] [Abstract][Full Text] [Related]
14. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.
Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K
J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062
[TBL] [Abstract][Full Text] [Related]
15. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice.
Yan Y; Yamada K; Mizoguchi H; Noda Y; Nagai T; Nitta A; Nabeshima T
Neuroscience; 2007 Apr; 146(1):50-9. PubMed ID: 17317018
[TBL] [Abstract][Full Text] [Related]
17. Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine.
Narita M; Suzuki M; Kuzumaki N; Miyatake M; Suzuki T
Ann N Y Acad Sci; 2008 Oct; 1141():96-104. PubMed ID: 18991953
[TBL] [Abstract][Full Text] [Related]
18. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator.
Gualandris A; Jones TE; Strickland S; Tsirka SE
J Neurosci; 1996 Apr; 16(7):2220-5. PubMed ID: 8601802
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.
Yepes M; Wu F; Torre E; Cuellar-Giraldo D; Jia D; Cheng L
Neuroscience; 2016 Apr; 319():69-78. PubMed ID: 26820595
[TBL] [Abstract][Full Text] [Related]
20. The role of tissue-type plasminogen activator system in amphetamine-induced conditional place preference extinction and reinstatement.
Bahi A; Kusnecov A; Dreyer JL
Neuropsychopharmacology; 2008 Oct; 33(11):2726-34. PubMed ID: 18256596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
